background
wheez
ill
among
young
children
common
risk
factor
asthma
howev
determin
childhood
bronchial
reactiv
key
featur
asthma
larg
unknown
aim
studi
determin
patient
characterist
first
sever
virusinduc
wheez
episod
associ
pulmonari
function
preschool
age
method
studi
consist
children
present
first
wheez
episod
age
month
studi
entri
viral
etiolog
rhinoviru
genom
load
atop
clinic
characterist
standard
questionnair
analyz
followup
visit
impuls
oscillometri
exercis
challeng
perform
result
studi
entri
mean
age
children
month
sd
rhinoviru
posit
sensit
followup
visit
four
year
later
mean
age
children
month
sd
use
asthma
medic
regularli
discontinu
test
children
bronchial
reactiv
chang
mean
crude
valu
resist
exercis
challeng
bronchodil
present
nine
children
children
atop
sensit
time
first
wheez
episod
often
like
develop
bronchial
reactiv
odd
ratio
p
children
without
sensit
signific
associ
found
conclus
atop
sensit
time
first
sever
wheez
episod
import
earli
risk
factor
increas
bronchial
reactiv
preschool
age
bronchial
reactiv
impuls
oscillometri
pulmonari
function
sensit
wheez
previou
studi
shown
earli
wheez
induc
rhinoviru
andor
associ
sensit
import
risk
factor
recurr
wheez
asthma
like
reveal
underli
airway
inflamm
weak
viral
defens
mechan
howev
factor
influenc
bronchial
reactiv
children
poorli
character
previou
studi
shown
earlylif
factor
earlyonset
atopi
famili
histori
asthma
matern
smoke
exposur
trafficrel
air
pollut
preterm
birth
low
birth
weight
may
associ
decreas
pulmonari
function
later
childhood
two
studi
shown
wheez
young
age
induc
rhinoviru
may
associ
decreas
pulmonari
function
increas
airway
reactiv
later
childhood
studi
shown
compar
associ
respiratori
syncyti
viru
rsv
induc
wheez
reduc
pulmonari
function
howev
earlier
studi
mainli
includ
older
children
data
first
virusinduc
wheez
episod
pulmonari
function
test
young
children
challeng
impuls
oscillometri
io
method
test
pulmonari
function
tidal
breath
key
measur
io
respiratori
resist
rr
indic
energi
loss
due
resist
forc
airflow
airway
clinic
interpret
indic
obstruct
io
childfriendli
requir
minimum
cooper
success
use
age
year
forward
finland
populationbas
refer
valu
avail
children
age
year
secondari
strategi
prevent
asthma
initi
time
first
wheez
episod
howev
known
patient
characterist
time
first
acut
wheez
episod
predict
abnorm
pulmonari
function
later
childhood
thu
first
studi
investig
associ
patient
characterist
first
acut
sever
virusinduc
wheez
episod
subsequ
pulmonari
function
bronchial
reactiv
atop
sensit
diagnos
first
acut
sever
wheez
episod
associ
increas
bronchial
reactiv
reduc
lung
function
preschool
age
result
import
consid
design
earli
intervent
trial
secondari
prevent
asthma
among
children
suffer
first
acut
sever
wheez
episod
age
year
aim
determin
pulmonari
function
age
year
reactiv
exercis
bronchodil
io
also
test
earlylif
factor
predict
exercis
bronchodilationinduc
bronchial
reactiv
hypothes
patient
characterist
rhinoviru
etiolog
atopi
time
first
sever
wheez
episod
would
associ
pulmonari
function
increas
bronchial
reactiv
measur
io
year
first
wheez
episod
th
od
studi
part
larger
studi
carri
turku
univers
hospit
recruit
june
march
aim
origin
studi
assess
effect
cours
oral
prednisolon
first
dose
mgkg
mgkg
day
two
divid
dose
maximum
dose
mgday
prednisolon
mg
tablet
leira
takeda
helsinki
finland
children
first
acut
rhinovirusinduc
wheez
episod
hospit
treat
emerg
room
tertiari
hospit
use
random
doubleblind
placebocontrol
parallel
design
inclus
criteria
age
month
first
acut
wheez
episod
confirm
parent
report
medic
record
deliveri
week
children
chronic
nonatop
ill
need
intens
care
unit
treatment
previou
system
inhal
corticosteroid
ic
treatment
exclud
studi
studi
approv
ethic
committe
turku
univers
hospit
commenc
obtain
written
inform
consent
guardian
trial
doubleblind
followup
studi
entri
guardian
complet
standard
questionnair
form
child
physic
examin
nasopharyng
aspir
sampl
taken
use
standard
procedur
studi
entri
multiplex
seeplex
ace
detect
seegen
seoul
korea
inhous
singl
pcr
test
use
detect
adenoviru
coronaviru
enterovirus
human
bocaviru
human
metapneumoviru
influenza
b
virus
parainfluenza
viru
type
rhinoviru
type
b
c
rsv
b
depart
virolog
univers
turku
rhinoviru
sequenc
previous
describ
analyz
collabor
univers
wisconsinmadison
human
also
analyz
use
serolog
previous
describ
analyz
viru
genom
load
steril
flock
swab
catalog
number
copan
brescia
itali
first
dip
aspir
dilut
ml
phosphatebuff
salin
genom
load
analyz
rna
rhinovirusposit
sampl
quantit
rtpcr
use
known
concentr
plasmid
plasmid
receiv
glyn
stanway
univers
colchest
essex
uk
describ
elsewher
serum
level
allergenspecif
immunoglobulin
e
ige
phadiatop
combi
phadia
uppsala
sweden
blood
eosinophil
count
b
airway
hyperrespons
revers
airflow
obstruct
measur
use
io
impuls
oscillatori
signal
hz
use
output
pressur
flow
signal
analyz
amplitud
phase
differ
determin
airway
resist
rr
variabl
reflect
energi
loss
due
resist
forc
airflow
reactanc
xr
indic
viscoelast
properti
small
airway
rr
xr
compon
total
respiratori
imped
zr
result
phase
pressur
chang
airflow
frequenc
depend
resist
drrsdf
determin
use
linear
regress
resist
data
point
obstruct
rr
increas
result
increas
drrsdf
xr
decreas
due
peripher
stiffen
result
obstruct
technic
realiz
io
describ
detail
appendix
baselin
measur
exercis
test
conduct
children
urg
run
min
exercis
level
heart
rate
held
estim
maximum
heart
rate
age
assess
heart
rate
monitor
polar
sport
tester
polar
elektro
ltd
kempel
finland
io
measur
repeat
min
exercis
test
final
revers
airflow
obstruct
assess
io
min
bronchodil
inhal
microgram
salbutamol
ventolin
administ
spacer
babyhal
product
glaxosmithklin
brentford
uk
result
proport
height
child
rr
hz
categor
patholog
exerciseinduc
chang
mean
crude
valu
bronchodilatorinduc
chang
mean
crude
valu
malmberg
beydon
children
atop
sensit
posit
test
cutoff
level
kul
ige
specif
test
allergen
codfish
cow
milk
egg
peanut
soybean
wheat
cat
dog
hors
birch
mugwort
timothi
cladosporium
herbarum
dermatophagoid
pteronyssinu
eczema
studi
entri
physicianmad
diagnosi
accord
pruritu
typic
morpholog
chronic
diseas
defin
atop
sensit
diagnos
children
exercis
test
conduct
due
refus
run
two
children
due
sever
asthma
symptom
one
child
children
bronchodil
andor
exercis
test
n
includ
analysi
includ
n
exclud
n
particip
differ
one
anoth
concern
patient
characterist
shown
tabl
tabl
studi
entri
mean
age
studi
subject
month
sd
hospit
baselin
io
measur
one
child
patholog
rr
tabl
associ
baselin
valu
io
tabl
baselin
rr
valu
associ
factor
shown
tabl
data
shown
increas
bronchial
reactiv
diagnos
children
eight
chang
diagnos
exercis
test
rr
hz
increas
one
children
rr
likewis
patient
characterist
shown
tabl
associ
bronchial
reactiv
oc
treatment
first
wheez
episod
affect
pulmonari
function
four
year
later
signific
differ
baselin
io
paramet
p
exerciseinduc
bronchial
reactiv
p
prednisolon
placebo
group
children
abl
discontinu
ic
use
exerciseinduc
chang
rr
hz
greater
nonic
user
ci
p
associ
remain
adjust
analysi
tabl
tabl
result
without
children
use
continu
ic
treatment
followup
visit
markedli
differ
data
shown
knowledg
first
studi
investig
associ
patient
characterist
first
acut
sever
virusinduc
wheez
episod
subsequ
pulmonari
function
bronchial
reactiv
later
childhood
main
find
atop
sensit
aeroallergen
food
sensit
first
wheez
episod
associ
increas
bronchial
reactiv
preschool
age
find
signific
associ
rhinoviru
genom
load
viru
infect
patient
characterist
studi
entri
later
pulmonari
function
bronchial
reactiv
previou
studi
report
earli
atop
sensit
previou
studi
shown
parent
asthma
matern
smoke
associ
baselin
pulmonari
function
andor
bronchial
reactiv
studi
also
found
associ
patient
characterist
decreas
pulmonari
function
followup
age
year
vitamin
found
potenti
prevent
infecti
diseas
atop
ill
innat
adapt
immun
respons
studi
patient
characterist
data
care
assembl
level
analyz
howev
find
associ
patient
characteri
earlier
studi
shown
decreas
baselin
pulmonari
function
case
year
virusinduc
bronchiol
studi
proport
patholog
pulmonari
function
baselin
low
detect
rate
exerciseinduc
bronchial
reactiv
also
rel
low
compar
earlier
studi
studi
twelv
children
abl
discontinu
ic
medic
asthma
may
partli
explain
low
detect
rate
increas
bronchial
reactiv
howev
major
children
use
ic
medic
discontinu
least
four
week
io
test
accord
finnish
guidelin
strength
studi
includ
prospect
design
new
focu
first
wheez
episod
comprehens
viral
diagnost
use
io
pulmonari
function
test
good
qualiti
io
measur
discontinu
regular
asthma
control
medic
major
asthmat
children
test
allergenspecif
ige
use
character
atop
sensit
children
care
examin
physician
standard
questionnair
use
provid
detail
character
children
howev
studi
limit
patient
hospit
first
acut
wheez
episod
make
result
applic
sever
end
ill
rel
small
studi
popul
preclud
analysi
rhinoviru
speci
associ
respiratori
virus
spirometri
outcom
reason
challeng
exercis
test
ensur
continu
heart
rate
monitor
ventil
measur
purpos
conclus
atop
sensit
diagnos
first
acut
sever
wheez
episod
associ
increas
bronchial
reactiv
reduc
lung
function
preschool
age
clinic
result
suggest
test
atop
sensit
time
first
wheez
episod
may
prognost
signific
respect
lung
function
result
also
import
consid
design
earli
intervent
trial
secondari
prevent
asthma
thank
mr
tiina
peromaa
valuabl
help
conduct
exercis
test
heidi
jokinen
biomed
laboratori
scientist
help
laboratori
analys
dr
pekka
malmberg
phd
guidanc
io
methodolog
mr
smith
jaeger
germani
provid
us
io
devic
studi
author
conflict
interest
connect
paper
